Jeffrey Sevigny - 01 Apr 2025 Form 4 Insider Report for Rapport Therapeutics, Inc. (RAPP)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RAPP	Stock Option (Right to Buy)	Award	$0	+300,000		$0.000000	300,000	01 Apr 2025	Common Stock	300,000	$9.56	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	25% of the shares underlying this option shall vest and become exercisable on March 3, 2026, with the remaining shares vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.